Clinical Trial Update: Trobalt™ Products Risk Survey

View source ↗

Summary

GlaxoSmithKline reports a completed risk survey related to Trobalt (ezogabine) for epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Trobalt (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Status: COMPLETED